XLIFE SCIENCES AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.1 CHF | +0.30% |
|
0.00% | -33.67% |
| Apr. 23 | Xlife Sciences Posts Higher FY23 Profit; Revenue Falls | MT |
| Feb. 29 | Xlife Sciences AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 211M | - | - | ||||
| 56.65B | - | |||||
| 39.44B | ||||||
| 39.03B | ||||||
| 26.75B | ||||||
| 26.86B |
- Stock Market
- Equities
- XLS Stock
- Charts Xlife Sciences AG
- Sector Chart
